Congratulations to Assistant Professor Dr. Huy Bui, who has been named a 2017 CIFAR Azrieli Global Scholar!
Collaboration between departmental members Drs. D. Reinhardt and P. Campeau has received new 5-year funding from the Canadian Institutes of Health Research for the grant entitled “Role of fibronectin mutations in spondylometaphyseal dysplasia and idiopathic scoliosis” in the amount of $680,850. Congratulations!
Industry and academia to share expertise in effort to develop improved methods to produce and characterize antibodies and reagents for neurological research
Canadian Open Neuroscience Platform will make disseminating and publishing data easier
Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.
Volume in brain region linked to physiological changes characteristic of AD
New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
Industry and academia team up for the benefit of people suffering from ALS
A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.
Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million
Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million.
Brain stimulation can change how much we enjoy and value music
Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.
Researchers develop method that could one day be used in brain trauma lawsuits
Lawyers representing both sides in concussion lawsuits against sports leagues may eventually have a new tool at their disposal: a diagnostic signature that uses artificial intelligence to detect brain trauma years after it has occurred.
Deep learning transforming neuroscience research
In an article published in Nature on Feb. 15, 2017, researchers, including principal investigators from the Montreal Neurological Institute’s McConnell Brain Imaging Centre (BIC), used magnetic resonance imaging (MRI) to predict the development of autism in babies.
Once again the Cystic Fibrosis Translational Research Centre (CFTRc) team from McGill University participated in the annual Walk to Make Cystic Fibrosis History. As a nation, Canada raised $3 million dollars and counting for Cystic Fibrosis research and care.
For McGill scientists specializing in protein-traffi cking diseases such as cystic fi brosis (CF), October 17, 2011 marked a monumental event with the opening of McGill’s Cystic Fibrosis Translational Research Centre (CFTRc) in the McIntyre Medical Sciences Building. Celebrated by a one-day symposium highlighting McGill’s proven strengths in this research area, the Centre brings society one step closer to eradicating CF.
Read the whole article HERE.
Gergely Lukacs, from the Department of Physiology, talks about cystic fibrosis, a paradigm of conformational diseases. A "Soup and Science" presentation.
Watch the whole presentation on YouTube HERE.
David Thomas, professor and chair in the Department of Biochemistry at McGill University addresses progress in molecular biology and the latest strategies for tackling genetic disease.
Watch the whole episode HERE.
The research group of Prof Xinyu Liu is developing a portable, paper-based biosensor for point-of-care diagnosis of HIV and hepatitis C virus (HCV) co-infections. The research, led by graduate student Chen Zhao, has been published in the journal Biomicrofluidics. The article has been selected as an Editor’s Pick of the journal and has been featured by Science Daily, American Institute of Physics (AIP), the Electrochemical Society and other science news websites.